Pure Global
NCT01422018

Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy

Seoul St. Mary's Hospital·ClinicalTrials.gov·drug
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Complications
Drug/Device/Intervention
Avastin (bevacizumab)
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Seoul St. Mary's Hospital
Location
Seocho, South Korea
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2011
End date
Feb 01, 2012
Enrollment
10 participants
Primary outcome

Changes in best-corrected visual acuity (BCVA)

Summary

Purpose: To evaluate the efficacy of intravitreal bevacizumab (IVB) on focal edema with hard
 exudates secondary to diabetic retinopathy.
 
 Design: Prospective interventional case series. Participants: Ten eyes of 10 consecutive
 patients showing focal edema with hard exudates secondary to diabetic retinopathy which are
 not eligible for focal laser photocoagulation due to central location ( 500 µm from fovea).

ICD-10 classifications
Unspecified diabetes mellitus without complicationsOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus without complicationsUnspecified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT01422018
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT01422018 through Pure Global AI's free database. This phase not specified trial is sponsored by Seoul St. Mary's Hospital and is currently status unknown. The study focuses on Diabetes Complications. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.